Re:Birth Re:Set
Natural health product licensed in Canada
- Licence holder
- TERI-BIO Inc.
- NPN or DIN-HM
- 80147569
- Status
- Active licence
- Licence date
- 3 March 2026
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 5,6-Dihydro-9,10-diméthoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium Source : Coptis chinensis - Rhizome | 200 mg | Not calculated |
| 5,6-Dihydro-9,10-diméthoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium Source : Berberine hydrochloride | 200 mg | Not calculated |
| Melissa officinalis Source : Melissa officinalis - Herb top Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 800 mg | 80 mg | Not calculated |
| Trigonella foenum-graecum Source : Trigonella foenum-graecum - Graine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 700 mg | 70 mg | Not calculated |
| Lagerstroemia speciosa Source : Lagerstroemia speciosa - feuille Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 500 mg Potency : 1 % Corosolic acid | 50 mg | Not calculated |
| Acide 1,2-dithiolane-3-pentanoïque, (R) Source : Sodium R-(+)-Lipoate | 30 mg | Not calculated |
| trans-Resvératrol Source : Reynoutria Japonica - racine | 20 mg | Not calculated |
| trans-Resvératrol Source : Resvératrol | 20 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Hydroxypropyl méthylcellulose, Acide stéarique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80147569
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.